Paciaroni, K. (2025) “THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib.: Dual Myeloid Disorder Treated with Two Drug Association”, Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025023. doi: 10.4084/MJHID.2025.023.